Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study
- Efficient screening processes may reduce participant and site burden in clinical trials -
- Efficient screening processes may reduce participant and site burden in clinical trials -